NCT06419686View on ClinicalTrials.gov

The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

May 31, 2024

Study Completion Date

July 31, 2024

Conditions
Effect of iv Administration of GIP and Alanine
Interventions
OTHER

Placebo (saline)

Intravenous saline during experimental days.

DRUG

GIP

Intravenous GIP administration during experimental days.

DRUG

Alanine

Intravenous alanine administration during experimental days.

DRUG

GIP + alanine

Intravenous administration of GIP and alanine during experimental days.

Trial Locations (1)

2900

RECRUITING

Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER